PRP delivers concentrated growth factors directly to injury sites with stronger clinical trial evidence especially for tendon injuries and mild knee arthritis BPC-157 works systemically through VEGF upregulation and nitric oxide modulation with strong animal data but limited large-scale human trials What it may miss It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation
We dont know, in 10, 20, 30 years, is this going to be something that could cause a malignancy or increase the risk of heart disease. Myers said he has seen patients using unapproved peptides without disclosing it to him, and that he has spoken with physicians who have used peptides on themselves with mixed anecdotal results
Adding GH secretagogues (ipamorelin) to a SARMs cycle can amplify results, but you are managing two layers of hormonal manipulation
A lower-dose maintenance attempt is a practical translation supported by directional real-world evidence, not a trial-proven protocol
Combining these with a KPV spray adds NF-B-mediated anti-inflammatory coverage creating a three-peptide gut protocol addressing inflammation (KPV), vascular repair (BPC-157), and cellular repair mechanics (TB-500)
Well make sure you have everything you need to feel confident and well.